L. V. Prasad Eye Institute, Hyderabad, Telangana, India.
Cornea Service, Wills Eye Hospital, Philadelphia, USA.
Indian J Ophthalmol. 2023 Mar;71(3):698-706. doi: 10.4103/ijo.IJO_1964_22.
Among the various indications for keratoplasty, failed graft is one of the commonest indications in many published series. It is well known that the major cause of graft failure is endothelial rejection. In the last two decades, there has been a major paradigm shift in the surgical management of corneal diseases, and component keratoplasty has emerged from the concept of replacing the layer that is actually diseased, rather than replacing the full-thickness cornea with the traditional penetrating keratoplasty. This has resulted in improved outcomes and the risk of endothelial rejection has reduced drastically, thus expanding the survival time of the graft. In recent years, reports of graft rejection in component keratoplasty have emerged, with each having a different presentation and responding to a different line of treatment. This review aims to summarize the presentation, diagnosis, and management of graft rejections in component keratoplasty.
在各种角膜移植适应证中,失败移植是许多已发表系列中的常见适应证之一。众所周知,移植失败的主要原因是内皮排斥。在过去的二十年中,角膜疾病的外科治疗发生了重大范式转变,成分性角膜移植已经从替换实际患病的层的概念中出现,而不是用传统的穿透性角膜移植替换整个角膜。这导致了更好的结果,内皮排斥的风险大大降低,从而延长了移植物的存活时间。近年来,出现了关于成分性角膜移植中移植物排斥的报告,每个报告都有不同的表现,并对不同的治疗方案有反应。本综述旨在总结成分性角膜移植中移植物排斥的表现、诊断和处理。